RECURRENT MUCOSAL MELANOMA
Clinical trials for RECURRENT MUCOSAL MELANOMA explained in plain language.
Never miss a new study
Get alerted when new RECURRENT MUCOSAL MELANOMA trials appear
Sign up with your email to follow new studies for RECURRENT MUCOSAL MELANOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Custom-Made vaccine trial launches for Tough-to-Treat cancers
Disease control Recruiting nowThis early-stage study is testing the safety of a personalized vaccine designed to train a patient's immune system to attack their specific cancer. It is for adults with advanced breast cancer, melanoma, or non-small cell lung cancer that has continued to grow despite standard tr…
Matched conditions: RECURRENT MUCOSAL MELANOMA
Phase: PHASE1 • Sponsor: Fred Hutchinson Cancer Center • Aim: Disease control
Last updated Mar 31, 2026 12:11 UTC
-
Double attack on rare cancer: can new drug combo stop deadly Melanoma's return?
Disease control Recruiting nowThis trial is for people with mucosal melanoma, a rare and aggressive cancer, that has been surgically removed. It tests whether adding a pill called cabozantinib to an immunotherapy drug (nivolumab) is better at preventing the cancer from returning than the immunotherapy alone. …
Matched conditions: RECURRENT MUCOSAL MELANOMA
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Mar 18, 2026 14:55 UTC